|
Lesley A. Stolz Ph.D. joined Sunesis in 2007 with more than a decade of biotechnology industry experience. Most recently she served as Senior Director Business Development for Aerovance Inc. where she led efforts to partner the company's Phase 2 asset for uncontrolled asthma. Dr. Stolz was Senior Director Business Development for GPC Biotech AG of Germany from 2002 to 2006 where she co-led the acquisition of Axxima Pharmaceuticals. From 2001 to 2002 Dr. Stolz served as Director Business Development for Cell Genesys Inc. with responsibility for identifying and negotiating partnerships for the company's cancer therapy research and development programs. Dr. Stolz received her Ph.D. and M.S. degrees from the University of Rochester and a B.S. from the University of Virginia. She conducted postdoctoral research at Harvard Medical School's Department of Biochemistry and Molecular Pharmacology. | 